Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma

Apollina Goel, Angela Dispenzieri, Susan M. Geyer, Suzanne Greiner, Kah Whye Peng, Stephen J. Russell

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds